1642.0000 1.70 (0.10%)
NSE Sep 23, 2025 10:18 AM
Volume: 17,999
 

1642.00
0.10%
Motilal Oswal
Eris Lifesciences (ERIS) posted lower-than-expected 4QFY25 performance. This has been largely due to a marginal slip in the execution, particularly in the insulin revenue.
Eris Lifesciences Ltd. has an average target of 1581.00 from 3 brokers.
More from Eris Lifesciences…
All earning calls
Investor presentations from Eris Lifesciences…
All investor presentations